- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
UPDATED Apr 24, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,639 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
GIG | kr34.10 | -1.7% | 24.0% | kr4.4b | kr49.20 | PE28x | E39.8% | n/a | Consumer Services | ||
NEWBRY | kr3.39 | -3.1% | -39.0% | kr82.2m | kr8.00 | PS3.6x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
HHR | AU$0.007 | -12.5% | -79.4% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
ELF | US$176.98 | 6.4% | 88.6% | US$9.8b | US$206.21 | PE75.9x | E27.2% | n/a | Household | ||
A108860 | ₩16,630.00 | 2.6% | -16.6% | ₩447.6b | n/a | PS8.4x | E98.9% | n/a | Software | ||
NVG | zł2.14 | -11.6% | 39.4% | zł74.9m | zł3.71 | PE7.7x | E28.5% | n/a | Diversified Financials | ||
AXSM | US$71.17 | 2.1% | 1.5% | US$3.5b | US$121.13 | PS12.5x | E60.7% | n/a | Pharmaceuticals & Biotech | ||
FDE | €34.40 | 7.5% | 1.2% | €179.9m | €64.07 | PE22.9x | E32.3% | n/a | Energy | ||
PRL | CA$22.81 | 7.0% | 248.2% | CA$802.2m | CA$24.37 | PE20.6x | E33.6% | 2.1% | Diversified Financials | ||
ELABS | kr16.90 | 21.4% | 42.0% | kr1.8b | kr25.00 | PS25.9x | E124.6% | n/a | Software | ||
NOHAL | kr22.20 | -3.5% | -7.5% | kr868.2m | kr32.50 | PS8.5x | E56.0% | n/a | Food, Beverage & Tobacco | ||
WAYS | kr22.35 | -4.9% | -58.3% | kr180.4m | kr39.75 | PS1.6x | E81.8% | 0% | Tech | ||
ZVRA | US$4.56 | -1.7% | -12.0% | US$191.7m | US$19.00 | PS6.9x | E63.6% | n/a | Pharmaceuticals & Biotech | ||
AGP | €7.66 | 0.3% | 105.9% | €132.6m | €12.75 | PE27x | E22.8% | n/a | Capital Goods | ||
GWIND | ₺26.50 | 3.8% | 67.8% | ₺14.3b | ₺39.79 | PE22.9x | E60.9% | 1.7% | Utilities | ||
CALTX | kr100.40 | -0.5% | -18.7% | kr5.4b | kr208.00 | PS4.5x | E48.8% | n/a | Pharmaceuticals & Biotech | ||
ALKT | US$24.49 | 2.7% | 107.7% | US$2.4b | US$28.70 | PS9x | E80.1% | n/a | Software | ||
ATAKP | ₺47.26 | 2.8% | n/a | ₺6.6b | ₺67.66 | PE22.2x | E72.8% | n/a | Food, Beverage & Tobacco | ||
ESTA | US$48.95 | -6.1% | -30.9% | US$1.4b | US$59.29 | PS8.1x | E65.4% | n/a | Healthcare | ||
RDUE | €9.50 | 0% | 3.9% | €59.4m | €10.50 | PE17.5x | E37.7% | n/a | Capital Goods | ||
GTHX | US$3.99 | -6.8% | 62.2% | US$218.7m | US$8.50 | PS2.5x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.57 | -8.6% | -39.2% | US$231.7m | US$26.06 | PS4.4x | E62.9% | n/a | Pharmaceuticals & Biotech | ||
APLT | US$4.31 | -10.8% | 183.6% | US$509.5m | US$11.60 | PS49.3x | E81.9% | n/a | Pharmaceuticals & Biotech | ||
ALNY | US$143.80 | -1.0% | -27.2% | US$18.5b | US$220.00 | PS9.9x | E60.6% | n/a | Pharmaceuticals & Biotech |